Deprescribing in nursing essays should centre on a decision: whether the expected benefits of continuing a particular medicine still justify its harms and burden for this person. A strong answer compares continuation, adjustment and supervised withdrawal, then explains how the team will review the decision.
This guide develops that decision analysis. For the broader question of whether a whole regimen is appropriate, start with critically discussing polypharmacy in nursing essays. Here, the unit of analysis is one proposed treatment change.
Deprescribing in nursing essays: define the decision
Write a single sentence identifying the medicine or treatment under consideration, its documented indication and why the team proposes a review. If the case omits the indication, make verification the first requirement. An unknown indication is a gap in the record, not proof that the medicine has no purpose.
NICE NG56 places treatment burden and individual priorities within multimorbidity management (NICE, 2016). That provides a foundation for asking whether the treatment still fits the person. It does not establish that withdrawal of a named medicine will improve this particular patient’s outcomes.
Separate a decision to review from a decision to stop. Your paragraph can conclude that a supervised review is justified while acknowledging that the available facts do not establish which option is safest. This is a defensible judgement when the scenario is incomplete.
Compare three options rather than assuming withdrawal
Prepare an options table before drafting. Include what the medicine is intended to achieve, the person’s reported experience and the evidence needed to compare alternatives. The table below is an original writing framework, not a prescribing protocol.
| Option | Question for your analysis | Evidence to obtain |
|---|---|---|
| Continue | Does the current benefit remain important and acceptable? | Current indication, response and patient preference |
| Adjust | Could an authorised change reduce burden while retaining benefit? | Medicine-specific information and clinical review |
| Withdraw under a plan | Does the balance favour stopping, with appropriate follow-up? | Withdrawal risks, recurrence risks and monitoring arrangements |
Avoid treating fewer tablets as the sole success measure. Your judgement should concern the person’s agreed goals. A regimen can become shorter without becoming better, and it can remain unchanged after a useful review.
Make patient choice part of the reasoning
Ask what the person wants to preserve or improve. Their priority might concern alertness, symptom control, practical burden or confidence in managing treatment. Use only preferences supplied in the case; otherwise, identify the discussion that would be needed.
A preference is not an extra sentence added after a clinical recommendation. It helps determine which benefits and burdens matter. For instance, an unwanted effect affecting daily functioning may carry more weight for one person than for another.
Describe how uncertainty would be explained in understandable language. An essay that states only that the patient agreed leaves the quality of the decision unclear. Explain the options discussed, what remained uncertain and how understanding would be checked. Distinguish the person’s stated view from your interpretation of it.
Address withdrawal and recurrence separately
NICE NG215 advises against abrupt cessation of the medicines it covers except in exceptional medical circumstances, and supports an individualised withdrawal approach (NICE, 2022). Apply that guidance within its actual scope rather than presenting one withdrawal rule for every drug.
In your analysis, distinguish withdrawal symptoms, return of the original condition and an unrelated new problem. These possibilities may be difficult to separate. Explain why a baseline, a timeline and a named review arrangement help the team interpret subsequent changes.
Therefore, do not invent a tapering schedule to make the essay appear practical. Where a medicine is named, consult its current product information and appropriate specialist guidance. An academic discussion can explain why a plan is needed without constructing an unsupported dose regimen.
Worked example: a request to stop a long-term medicine
Fictional teaching case: an adult taking several medicines asks whether one long-term treatment remains necessary because the daily regimen feels burdensome. The scenario gives no current symptom assessment or recent review.
A weak judgement is: “The medicine should be stopped to reduce polypharmacy.” It assumes both lack of benefit and a safe stopping process. A stronger argument identifies the missing information and compares reasonable options.
The request justifies a structured review of the treatment’s continuing indication and the person’s goals. Immediate cessation cannot be supported by the available case information. The discussion should compare continuation, adjustment and supervised withdrawal, identifying medicine-specific risks and an agreed follow-up plan before the prescriber authorises a change.
This original example demonstrates reasoning. It is not a clinical instruction. NICE NG5 supports structured medication review; your medicine-specific benefit and harm claims still need directly relevant evidence (NICE, 2015).
Evaluate the decision after the change
Finally, end the assignment section with a small evaluation plan. Record the agreed aim, what the team will observe, who will review the findings and what would trigger reassessment. Choose outcomes that reflect the reason for the change, rather than adding a generic list of observations.
Also consider whether the team may restart treatment or revise the plan. That does not automatically mean the review failed. A reasoned, monitored decision can generate information that was unavailable initially.
Check your final paragraph for ownership. “Monitor the patient” is incomplete if it does not identify the relevant finding or responsibility. For the preceding task of identifying a suspected problem, read recognising medicine-related harm in polypharmacy case studies.
Frame deprescribing as a decision with alternatives
Begin with the decision the case actually presents. A person may ask whether a treatment is still needed, report an unwanted effect or describe difficulty managing the regimen. Those concerns justify investigation, but they do not determine the outcome in advance.
Compare continuation, adjustment and supervised withdrawal. Explain what information would support each option and which uncertainties remain. A balanced comparison demonstrates that the essay is evaluating a decision rather than assuming that fewer medicines must be better.
Keep the unit of analysis clear. This article concerns one proposed treatment change. If the assignment asks about the appropriateness of the whole regimen, establish that broader framework separately and then explain how the individual decision fits within it.
Avoid equating a medicine count with treatment quality. A reduction may be helpful in one situation and inappropriate in another. The relevant question is whether the treatment continues to serve the person’s agreed goals with an acceptable balance of benefit, harm and burden.
Write a provisional conclusion before drafting the section. It might state that review is justified but that the evidence is insufficient to select an option. This helps every paragraph contribute to a defined judgement.
Deprescribing in nursing essays needs a continuing-indication check
First, identify why the prescriber started the medicine and what it should achieve now. The original indication may remain relevant, may have changed or may be unclear in the available record. Do not treat an undocumented indication as proof of unnecessary treatment.
Separate the historical reason from the present decision. A treatment can have been appropriate when started while still requiring review later. Equally, the passage of time does not independently establish that it should be stopped.
Record the evidence needed to judge continuing benefit. This may involve the person’s response, current priorities and medicine-specific information, depending on the scenario. Use only the findings supplied and identify additional assessment where needed.
Then connect the indication to the alternatives. What would continuation preserve? How might adjustment help? Finally, which benefits or burdens could supervised withdrawal change? These questions keep the comparison focused on the person’s care.
Your paragraph should not become a generic list of medicines-review tasks. Explain why the particular indication or information gap affects this decision. A precise account of uncertainty is more persuasive than a confident recommendation based on an incomplete record.
Make treatment burden concrete without inventing preferences
Treatment burden can concern practical work, understanding, unwanted effects or interference with daily life. In an assignment, specify which burden the person actually describes. Do not assume that a complex regimen is experienced in the same way by everyone.
If the case contains a direct preference, preserve its meaning. A person who asks for a simpler routine has not necessarily requested that a particular medicine be stopped. Explore the concern before selecting the response.
When preferences are absent, identify the discussion required rather than creating one. You can explain that the decision needs the person’s priorities without claiming to know what those priorities are.
Also distinguish a practical problem from a pharmacological one. Difficulty opening packaging, uncertainty about timing and an adverse effect may require different responses. Stopping treatment is not the automatic answer to every burden.
The critical task is to connect the burden to the available options. Explain whether it changes the acceptability of continuation, makes an authorised adjustment worth considering or supports discussion of withdrawal. That reasoning gives patient choice a substantive role rather than adding it as a closing phrase.
Compare benefits and harms on the same decision horizon
A treatment decision can involve benefits and burdens occurring over different periods. Your essay should identify the timeframe relevant to the person’s goals and the evidence. Avoid comparing an immediate burden with an unspecified future benefit as though both were fully known.
Use medicine-specific evidence for claims about expected effects. A general medicines-review guideline can support the need for structured discussion, but it cannot establish the size or timing of a named treatment’s benefit for this individual.
Keep absolute claims proportionate. “The medicine has no benefit” is different from “the available case information does not establish its current benefit”. The second statement identifies an evidence gap without inventing a clinical conclusion.
The same applies to harms. A recognised risk does not prove that the person has experienced it. Explain the finding, the possible relationship and the remaining uncertainty.
Then compare the options using the same question: which approach best fits the documented indication, relevant evidence and person’s priorities? This provides a coherent basis for judgement. It avoids allowing the most vivid concern to dominate simply because it is easier to describe.
Deprescribing in nursing essays should separate withdrawal from recurrence
Withdrawal symptoms and return of the original condition can create different questions after a treatment change. An essay should explain why they need to be distinguished without assuming that either will occur in every case.
Apply the relevant guidance within its scope. NG215 addresses particular medicines associated with dependence or withdrawal symptoms. Do not present its recommendations as an identical stopping rule for every medicine.
Use current medicine-specific information when discussing a named treatment. If the assessment does not provide enough detail for a regimen, explain the need for an appropriate plan rather than inventing a taper.
A baseline and timeline can help the team interpret subsequent findings. Describe what would need to be documented and reviewed in relation to the actual reason for the change. Avoid adding a generic monitoring list disconnected from the case.
The final judgement may be that review is appropriate while immediate cessation is unsupported. That conclusion can demonstrate safe, critical reasoning. It compares the need to reconsider treatment with the separate question of how a change could be undertaken appropriately.
Work through a fictional decision conversation
Imagine an adult who says that a long-term medicine routine feels burdensome and asks whether one treatment can be stopped. The scenario provides no recent review or detailed symptom assessment. A student initially concludes that stopping the medicine would reduce polypharmacy.
First, clarify what the request establishes. It identifies a concern and a reason for discussion. It does not establish that the medicine lacks benefit or that withdrawal is the person’s preferred option after understanding the alternatives.
Second, identify the missing evidence. The continuing indication, current response, relevant risks and person’s goals need clarification. Each gap should connect to a decision rather than become an unrelated checklist.
Third, compare reasonable options. Continuation may remain justified, an authorised adjustment may address the burden or supervised withdrawal may warrant consideration. The scenario does not yet determine which is best.
The improved paragraph should therefore support a structured review and informed discussion. It can explain why immediate cessation is not justified by the available information while still taking the person’s concern seriously. The strength lies in the comparison and the plan for resolving uncertainty.
Evaluate the decision through goals and follow-up
A shorter regimen is an easily counted outcome, but it is not a complete evaluation of a deprescribing decision. Return to the reason for the proposed change and the person’s agreed priorities.
State what would indicate that the plan is meeting its aim. Depending on the scenario, the relevant question might concern a reported burden, symptom control, understanding or an identified adverse effect. Do not invent a standard outcome for every treatment.
Identify who will review the findings and how a concern would be reassessed within the applicable clinical arrangements. “Monitor and review” is incomplete if it leaves the purpose and responsibility unclear.
Also consider revision of the plan. Restarting a treatment or choosing a different option does not automatically prove that the review failed. The assessment should examine whether the decision was reasoned, appropriately authorised and informed by follow-up.
In your conclusion, distinguish the quality of the decision process from the outcome observed. A defensible process does not guarantee a particular result, and a favourable result does not retrospectively justify an unsupported decision. Explain both with the evidence available in the case.
Keep the nursing role visible throughout the analysis
A deprescribing paragraph can become dominated by prescribing decisions. Bring the discussion back to the nurse’s contribution where the case supports it: recognising concerns, verifying information, supporting understanding, communicating findings and documenting relevant outcomes.
Do not imply that every nurse independently changes every medicine regimen. Describe the role, competence and authorisation applicable to the scenario. If these details are absent, use proportionate language about review through the appropriate team.
Make communication specific. Identify what the person reported, which medicine question needs clarification and what information should be available for the review. This is more useful than stating that the multidisciplinary team should be involved.
Preserve the person’s voice when evaluating the response. If the scenario records their priorities or experience after review, use those facts. If it does not, identify the information needed rather than supplying a reassuring quotation.
The final section should connect concern, evidence, options, authorised decision and evaluation. That sequence keeps deprescribing within a nursing argument and demonstrates why the task is more demanding than recommending that one medicine be removed.
Frequently asked questions
Is deprescribing always the right response to polypharmacy?
No. The relevant question is whether a particular treatment remains appropriate. A review may support continuation, adjustment or withdrawal.
Can I recommend a taper in my nursing essay?
Only discuss a specific regimen when the brief, case and current medicine-specific evidence justify it. Do not invent doses or present student analysis as an authorised prescription.
What makes a deprescribing paragraph critical?
It compares options, weighs patient priorities and evidence, explains uncertainty and specifies how the decision will be evaluated.
Does restarting treatment mean deprescribing failed?
Not automatically. Evaluate the team’s reasoning, authorisation and review against the person’s goals. A revised plan can reflect information gained through follow-up. Do not judge the whole process only by the final medicine count.
What if the person wants fewer medicines but the evidence is incomplete?
Take the concern seriously and identify the information needed for an informed comparison. Explain continuation, adjustment and supervised withdrawal as appropriate options for review. A preference to reduce burden does not justify inventing a safe stopping plan.
Key takeaways for your nursing assignment
Deprescribing analysis should compare realistic options and make the person’s priorities part of the reasoning. Verify the continuing indication, distinguish withdrawal from recurrence and identify the review arrangements needed. The conclusion may support a structured review without supporting immediate cessation. Judge the decision through its evidence, authorisation and follow-up rather than the number of tablets removed.
For source integration and accurate histories, read combining NMC and NICE in a case study and medication reconciliation in nursing assignments.
Use the examples as learning models and develop your own analysis from the assessment brief. If you seek editing or feedback, share only the information needed to review the argument and remove confidential details. Support can help you test clarity, evidence and structure; the submitted reasoning should remain your own.
Develop your own nursing argument
Request feedback on how your draft weighs benefits, withdrawal risks and the person’s priorities. Explore our nursing assignment editing and feedback and provide your assessment brief with your draft so the feedback addresses your learning outcomes.
References
National Institute for Health and Care Excellence (2016) Multimorbidity: clinical assessment and management (NG56). Available at: Multimorbidity: clinical assessment and management (NG56) (Accessed: 15 October 2026).
National Institute for Health and Care Excellence (2022) Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults (NG215). Available at: Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults (NG215) (Accessed: 15 October 2026).
National Institute for Health and Care Excellence (2015) Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes (NG5). Available at: Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes (NG5) (Accessed: 15 October 2026).
